Category: Healthcare
-
Date:
Peripheral Vasodilator Drugs Market Set to Surpass USD 9 Billion by 2031 Amid Rising Cardiovascular Burden and Innovation in Drug Development
The global peripheral vasodilator drugs market was valued at US$ 6.0 billion in 2022 and is projected to reach over US$ 9.0…
-
Date:
Global Radiopharmaceutical Theranostics Market Forecast 2031: Lutetium-177 Innovation, Precision Oncology, and Rising Cancer Burden to Drive Market Beyond USD 12.4 Billion
The global radiopharmaceutical theranostics market was valued at US$ 3.0 Bn in 2022 and is projected to surpass US$ 12.4 Bn by…
-
Date:
Global Antihyperlipidemic Drugs Market to Hit USD 20.1 Bn by 2031, Led by Pfizer, AstraZeneca, and Novartis
The global antihyperlipidemic drugs market is poised for steady growth, driven by the rising prevalence of cardiovascular diseases, increasing awareness of cholesterol…
-
Date:
Cardio-Selective Beta Blockers Market to Exceed US$ 10.1 Billion by 2031, Driven by Rising Cardiovascular Disease Burden and Aging Population
Cardio-selective Beta Blockers Market Overview Cardio-selective beta blockers, also known as beta-1 selective blockers, are a class of drugs designed to specifically…
-
Date:
Beta Blockers Market to Reach USD 14.4 Billion by 2031 as Demand Grows for Chronic Heart Disease Management
The global beta blockers market continues to witness steady growth, supported by the increasing prevalence of cardiovascular diseases (CVDs), rising geriatric population,…
-
Date:
Penicillin G Acylase Market to Surpass US$ 1.1 Billion by 2031 Driven by Rising Demand for Semi-Synthetic Antibiotics
The global penicillin G acylase market is witnessing steady growth, supported by increasing demand for semi-synthetic antibiotics and advancements in biocatalysis technologies.…
-
Date:
Severe Acute Respiratory Syndrome Treatment Market Size Forecast to USD 8.6 Billion by 2031 amid Declining Demand Post-Pandemic – Analysis by Transparency Market Research
Severe Acute Respiratory Syndrome Treatment Market Outlook 2031 The global severe acute respiratory syndrome (SARS) treatment market was valued at US$ 24.6…
-
Date:
Neonatal Respiratory Distress Syndrome Treatment Market Expected to Surpass USD 1.6 Billion by 2031 Amid Rising Premature Birth Rates and Advancements in Neonatal Care
The global Neonatal Respiratory Distress Syndrome (NRDS) Treatment Market is experiencing steady and meaningful expansion, driven by rising cases of premature births,…
-
Date:
Pediatric Asthma Treatment Market to Reach USD 14.4 Bn by 2031 | GSK, AstraZeneca, Novartis, Sanofi Lead Growth
The pediatric asthma treatment market is expected to witness steady growth through 2031, driven by the rising prevalence of asthma among children…
-
Date:
Aldosterone Receptor Antagonists Market to Exceed US$ 4.5 Billion by 2031, Driven by Rising Hypertension and Heart Failure Cases | TMR
Aldosterone Receptor Antagonists Market Overview Aldosterone Receptor Antagonists (ARAs) are a class of drugs used to block the action of aldosterone, a…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.
